Zim Laboratories Share Price

Zim Laboratories Share Price

NSE: ZIMLAB
|
Pharmaceuticals
|
S Cap
₹ 134.45
+₹0.65 (0.49%)
1D
Last updated 23 Sep, 2026, 11:38 IST

Zim Laboratories Share Price Today

As of 23 Sep 2026, Zim Laboratories share price is ₹134.45. The stock opened at ₹133.70, compared to its previous close of ₹133.80. During today's trading session, Zim Laboratories share price moved in the range of ₹130.75 to ₹135.80, with an average price of ₹133.28 for the day. Looking at its last 52-week, the stock has touched a low of ₹59.31 and a high of ₹144.49. On the performance front, Zim Laboratories share price has increased by 97.70% over the last six months and is up 77.85% on a year-on-year basis.

₹130.75
0.49% up today
₹135.80
1D LOW
1D HIGH

Zim Laboratories Returns Calculator

Circuit
L
H
₹107.04
₹160.56
52-week
L
H
₹59.31
₹144.49

About Zim Laboratories

Zim Laboratories Share Price
ISIN
INE518E01015
Sector Market Cap
₹ 717.41 Cr

ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.

Zim Laboratories Financial Highlights

  • Revenue: Zim Laboratories reported revenue of ₹385.78 crore in FY26 vs ₹384.81 crore in FY25. It showed an increase of 0.25% on a yearly basis.
  • Operating Profit: Zim Laboratories reported an operating profit of ₹8.21 crore in FY26 vs ₹18.01 crore in FY25. It showed a decrease of 54.41% on a year-on-year basis.
  • Net Profit: Zim Laboratories reported a net profit of ₹5.84 crore in FY26 vs ₹12.17 crore in FY25. It showed a decrease of 52.01% on a yearly basis.

Zim Laboratories Quarterly Result Highlights

  • Zim Laboratories reported revenue of ₹95.17 crore in Jun 2026, compared with ₹111.43 crore in Mar 2026, representing a decrease of 14.59% on a quarter-on-quarter (QoQ) basis.
  • Zim Laboratories reported an operating loss of ₹5.57 crore in Jun 2026, compared with ₹4.94 crore in Mar 2026, representing a decrease of 212.75% on a quarter-on-quarter (QoQ) basis.
  • Zim Laboratories reported a loss of ₹4.02 crore in Jun 2026, compared with ₹3.74 crore in Mar 2026, reflecting a decrease of 207.49% on a QoQ basis.
  • The earnings per share (EPS) of Zim Laboratories stood at ₹1.19 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
30.36%
FII
0.03%
Other DII
0.27%
Retail and other
68.28%
Mutual funds
1.07%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.02%
Mar 20260.00%
Jun 20260.03%
Mkt Cap Cr
717.41
P/E
193.77
P/B
2.44
ROE
1.97%
D/E
0.44
ROCE
5.07%
Div. Yield
0.00%
EPS(TTM)
1.22
Turnover
0.75
EV/EBITDA
20.47
Net Margin
1.19%
Op. Margin
10.37%
ROA
0.69%
Quick Ratio
0.85
Curr. Ratio
2.48
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Zim Laboratories outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Zim Laboratories appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Zim Laboratories earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Zim Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹374.40₹379.03₹367.42₹398.53
Other Income₹11.38₹5.78₹5.18₹6.41
Total Revenue₹385.78₹384.82₹372.61₹404.94
Total Expenses₹377.57₹366.81₹348.97₹369.59
Profit Before Tax₹8.21₹18.01₹23.64₹35.36
Tax₹2.37₹5.84₹6.40₹10.92
Profit After Tax₹5.84₹12.17₹17.25₹24.43
EPS - Basic₹1.19₹2.50₹3.54₹5.01
EPS - Diluted₹1.19₹2.50₹3.54₹5.01

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹8.21₹18.01₹23.64₹35.36
Income before WC changes₹37.31₹51.64₹45.65₹57.51
Change in Assets-₹7.30-₹5.21-₹34.69₹24.27
Change in Liabilities₹23.26-₹6.36₹7.91-₹37.11
Change in WC₹15.96-₹11.57-₹26.79-₹12.84
Cash flow from Operations₹49.53₹41.15₹16.28₹37.52
Cash flow from Investing-₹56.35-₹39.93-₹73.01-₹36.20
Cash flow from Financing₹28.19-₹9.10₹59.53₹0.55
Total Cash Flow₹23.18-₹7.65₹3.18₹3.00
Cash (Start of the year)₹1.95₹9.60₹6.42₹3.42
Cash (End of the year)₹25.12₹1.95₹9.60₹6.42

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹263.58₹240.97₹219.17₹150.63
Current Assets₹275.81₹231.31₹227.65₹190.95
Total Assets₹539.39₹472.27₹446.82₹341.58
Current Liabilities₹190.39₹166.36₹159.43₹110.79
Net Current Asset₹85.42₹64.94₹68.22₹80.16
Non-Current Liabilities₹52.84₹53.67₹48.65₹30.45
Equity Capital₹296.15₹252.24₹238.75₹200.35
Total Equity & Liabilities₹539.39₹472.27₹446.82₹341.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹370.48₹375.64₹365.47₹396.53
Other Income₹11.39₹5.62₹4.69₹6.43
Total Revenue₹381.87₹381.26₹370.16₹402.96
Total Expenses₹373.47₹363.64₹347.12₹367.04
Profit Before Tax₹8.40₹17.61₹23.04₹35.92
Tax₹2.44₹5.87₹6.28₹10.91
Profit After Tax₹5.97₹11.74₹16.76₹25.01
EPS - Basic₹1.22₹2.41₹3.44₹5.13
EPS - Diluted₹1.22₹2.41₹3.44₹5.13

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹8.40₹17.61₹23.04₹35.92
Income before WC changes₹36.10₹50.28₹44.40₹56.73
Change in Assets₹4.59-₹5.50-₹41.53₹22.54
Change in Liabilities₹10.56₹4.53₹11.17-₹37.06
Change in WC₹15.16-₹0.97-₹30.36-₹14.52
Cash flow from Operations₹47.66₹50.60₹11.47₹35.23
Cash flow from Investing-₹57.41-₹41.31-₹71.94-₹35.21
Cash flow from Financing₹28.19-₹9.10₹59.53₹0.55
Total Cash Flow₹18.43₹0.19-₹0.94₹0.57
Cash (Start of the year)₹0.36₹0.17₹1.11₹0.54
Cash (End of the year)₹18.80₹0.36₹0.17₹1.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹272.77₹248.04₹224.79₹156.23
Current Assets₹252.43₹216.35₹217.71₹178.64
Total Assets₹525.20₹464.39₹442.50₹334.87
Current Liabilities₹186.01₹166.20₹161.90₹110.24
Net Current Asset₹66.42₹50.15₹55.82₹68.40
Non-Current Liabilities₹52.84₹53.67₹48.65₹30.45
Equity Capital₹286.35₹244.51₹231.95₹194.18
Total Equity & Liabilities₹525.20₹464.39₹442.50₹334.87
* All values are in INR Crore
Qty
Bid
5
134.26
7
134.22
20
134.21
9
134.02
15
134.01
Ask
Qty
134.45
7
134.53
9
134.54
3
134.78
7
134.79
30
Bid Total: 56
Ask Total: 56
Buy orders: 50%
Sell orders: 50%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
57.18
Neutral
ATR (14)
9.08
Neutral
STOCH(9,6)
39.71
Neutral
STOCH RSI (14)
14.4
Bullish
ADX(9)
33.45
Bearish
UO(9)
61.04
Neutral
ROC(12)
4.51
Bullish
WillR(14)
-37.92
Neutral
Period
Simple value
Exponential vaue
5D
135.53
134.66
10D
134.94
133.76
20D
130.43
130.47
50D
121.69
123.37
100D
115.45
114
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep1L
18 Sep1L
17 Sep2L
16 Sep1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Zim Laboratories Share Price
Zim Laboratories
Pharmaceuticals
Add Stock
Add Another

Zim Laboratories Share Price FAQs

Zim Laboratories share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837